CASP3 and neoplasm: Meanwhile, ML210 and enzalutamide co-treatment in vivo in SCID mice could more effectively inhibit tumor growth, Ki67 and induce Cleaved-Caspase-3 expression (Fig. S8A, B), and reactivate H2O2 level (Fig. S8C).